The median survival time of patients with advanced gastric cancer (GC) who received radiotherapy and chemotherapy was <1 year. Epithelial-mesenchymal transformation (EMT) gives GC cells the ability to invade, which is an essential biological mechanism in the progression of GC. The long non-coding RNA (lncRNA)-based competitive endogenous RNA (ceRNA) system has been shown to play a key role in the GC-related EMT process.
View Article and Find Full Text PDFBackground: Gastric signet ring cell carcinoma (GSRCC) is a rare disease associated with poor prognosis. A prognostic nomogram was developed and validated in this study to assess GSRCC patients' overall survival (OS).
Methods: Patients diagnosed with GSRCC from the Surveillance, Epidemiology, and End Results (SEER) database (2004-2016) and the First Hospital of China Medical University (CMU1h) were enrolled in this retrospective cohort study.
Evidence indicates that the lipid scavenger receptor CD36 has pro-metastatic functions in several cancers. Although CD36 expression correlates with an unfavorable prognosis in gastric cancer (GC), its specific contribution to disease onset, progression, and/or metastasis remains unclear. Using bioinformatics analyses, we ascertained that CD36 expression was increased in metastatic GC specimens in The Cancer Genome Atlas and Gene Expression Omnibus databases and correlated with poor prognosis.
View Article and Find Full Text PDFA digital medical health system named Tianxia120 that can provide patients and hospitals with "one-step service" is proposed in this paper. Evolving from the techniques of Internet of Medical Things (IoMT), medical dig data, and medical Artificial Intelligence, the system can systematically promote the change of service status between doctors and patients from "passive mode" to "proactive mode" and realize online service that is similar to offline medical treatment scenarios. The system consists of a patient terminal and a doctor terminal.
View Article and Find Full Text PDF